In this special episode recorded live from Adopt AI Grand Palais, we speak with Reda Guiha, President of Pfizer France. The conversation explores how one of the world's leading pharmaceutical companies is implementing artificial intelligence across its operations and what this means for the future of healthcare.

Topics Covered:
- Pfizer's role in building Europe's AI healthcare ecosystem through partnerships
- Achieving 25-30% efficiency improvements in preclinical programs through AI
- Real-world AI diagnostics for rare diseases like transthyretin amyloidosis
- Moving from reactive to proactive healthcare systems using AI
- Tripling clinical trial success rates from 7% to 24% with AI integration
- Key success factors for AI in healthcare: scientific rigor and global scalability
- Advice for startups seeking pharmaceutical partnerships
- The shift toward personalized patient care and communication

Credits:
Production: MedShake Studio
Host: Anca Petre

Hosted on Ausha. See ausha.co/privacy-policy for more information.